Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event
- PMID: 2329411
- DOI: 10.1016/s0022-3476(05)82711-8
Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event
Abstract
The origin of autoantibody production was studied with the use of antibody to the alternative pathway C3 convertase (C3 nephritic factor (C3NeF), as a model. Pokeweed mitogen stimulation of peripheral mononuclear cells from newborn infants, normal adults, and patients with membranoproliferative glomerulonephritis indicated that the ability to make C3NeF is apparently present in everyone from the time of birth. In addition, C3NeF appeared to express a single or very limited idiotope (21/21 isolates). The data also suggest that the elaboration of C3NeF may approximate an antibody response after immunization. Thus the C3NeF fraction of the total IgG or IgM produced in culture by pokeweed mitogen-stimulated mononuclear cells from normal neonates and adults, as well as from patients, was in the range of the production of specific antibody. Further, both IgG and IgM C3NeF produced by cells from these normal individuals, including newborn infants, had an affinity for antigen (10(8) to 10(9) L/mol) that was also in the range of specific antibody. Most of the autoantibody molecules (5/7) from serum were IgG3; two B cell clones producing C3NeF were CD5-negative. These experiments indicate that unmutated germline genes are used in the production of C3NeF and that a limited spectrum of antiidiotypic antibodies regulate its production.
Similar articles
-
Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis.Clin Immunol Immunopathol. 1990 Oct;57(1):10-8. doi: 10.1016/0090-1229(90)90018-l. Clin Immunol Immunopathol. 1990. PMID: 1697516
-
Human anti-idiotypic antibody responses to autoantibody against the alternative pathway C3 convertase.Clin Immunol Immunopathol. 1990 Oct;57(1):19-31. doi: 10.1016/0090-1229(90)90019-m. Clin Immunol Immunopathol. 1990. PMID: 2394034
-
Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinity.J Immunol. 1992 Jan 1;148(1):137-41. J Immunol. 1992. PMID: 1727863
-
On the origin and control of C3NeF.In Vivo. 1988 Jan-Feb;2(1):79-81. In Vivo. 1988. PMID: 2979821 Review.
-
Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.Front Immunol. 2019 Apr 24;10:886. doi: 10.3389/fimmu.2019.00886. eCollection 2019. Front Immunol. 2019. PMID: 31068950 Free PMC article. Review.
Cited by
-
Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation.Kidney Int. 2012 Nov;82(10):1084-92. doi: 10.1038/ki.2012.250. Epub 2012 Aug 1. Kidney Int. 2012. PMID: 22854646 Free PMC article.
-
Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).Clin Exp Immunol. 1994 Feb;95(2):316-21. doi: 10.1111/j.1365-2249.1994.tb06530.x. Clin Exp Immunol. 1994. PMID: 8306508 Free PMC article.
-
Acquired drivers of C3 glomerulopathy.Clin Kidney J. 2025 Jan 27;18(3):sfaf022. doi: 10.1093/ckj/sfaf022. eCollection 2025 Mar. Clin Kidney J. 2025. PMID: 40052168 Free PMC article. Review.
-
Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy Phenotype.J Am Soc Nephrol. 2025 Feb 1;36(2):264-273. doi: 10.1681/ASN.0000000000000499. Epub 2024 Sep 26. J Am Soc Nephrol. 2025. PMID: 39325562
-
Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).Clin Exp Immunol. 1992 Sep;89(3):479-84. doi: 10.1111/j.1365-2249.1992.tb06984.x. Clin Exp Immunol. 1992. PMID: 1516262 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous